2018

Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer.

Afshar Oromieh A, Debus N, Uhrig M, Hope TA, Evans MJ, Holland-Letz T, Giesel FL, Kopka K, Hadaschik B, Kratochwil C, Haberkorn U

Tracer uptake in mediastinal and paraaortal thoracic lymph nodes as a potential pitfall in image interpretation of PSMA ligand PET/CT.

Afshar Oromieh A, Sattler LP, Steiger K, Holland-Letz T, da Cunha ML, Mier W, Neels O, Kopka K, Weichert W, Haberkorn U

Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional Aβ deposition rate and plaque burden at treatment initiation

Brendel M, Jaworska A, Overhoff F, Blume T, Probst F, Gildehaus FJ, Bartenstein P, Haass C, Bohrmann B, Herms J, Willem M, Rominger A

Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer’s Disease Patients with Depressive Symptoms.

Brendel M, Sauerbeck J, Greven S, Kotz S, Scheiwein F, Blautzik J, Delker A, Pogarell O, Ishii K, Bartenstein P, Rominger AO

Preparation and preclinical evaluation of a 68Ga-labelled c(RGDfK) conjugate comprising the bifunctional chelator NODIA-Me

Läppchen T, Holland JP, Kiefer Y, Bartholomä MD

In vitro and in vivo evaluation of the bifunctional chelator NODIA-Me in combination with a prostate-specific membrane antigen targeting vector

Läppchen T, Kiefer Y, Holland JP, Bartholomä MD

Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program.

Balmelli C, Railic N, Siano M, Feuerlein K, Cathomas R, Cristina V, Güthner C, Zimmermann S, Weidner SE, Pless M, Stenner F, Rothschild SI

Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?

Beyer L, Meyer-Wilmes J, Schönecker S, Schnabel J, Brendel E, Prix C, Nübling G, Unterrainer M, Albert NL, Pogarell O, Perneczky R, Catak C, Bürger K, Bartenstein P, Bötzel K, Levin J, Rominger AO, Brendel M

Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study

Blume T, Focke C, Peters F, Deussing M, Albert NL, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Ozmen L, Baumann K, Bartenstein P, Rominger A, Herms J, Brendel M

Feasibility and robustness of dynamic 18F-FET PET based tracer kinetic models applied to patients with recurrent high-grade glioma prior to carbon ion irradiation

Debus C, Afshar Oromieh A, Floca R, Ingrisch M, Knoll M, Debus J, Haberkorn U, Abdollahi A

Rate of β-amyloid accumulation varies with baseline amyloid burden: Implications for anti-amyloid drug trials

Guo T, Dukart J, Brendel M, Rominger AO, Grimmer T, Yakushev I

The assessment of correlation and prognosis among <sup>18</sup>F-FDG uptake parameters, Glut1, pStat1 and pStat3 in surgically resected non-small cell lung cancer patients

Kaida H, Azuma K, Kawahara A, Sadashima E, Hattori S, Takamori S, Akiba J, Fujimoto K, Rominger A, Murakami T, Ishii K, Ishibashi M

Performance of 111In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy

Mix M, Reichel K, Stoykow C, Bartholomä M, Drendel V, Gourni E, Wetterauer U, Schultze-Seemann W, Meyer PT, Jilg CA

F-PSMA-1007 PET/CT at 60 and 120 minutes in patients with prostate cancer: biodistribution, tumour detection and activity kinetics.

Rahbar K, Afshar Oromieh A, Bögemann M, Wagner S, Schäfers M, Stegger L, Weckesser M

Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer

Rahbar K, Afshar Oromieh A, Seifert R, Wagner S, Schäfers M, Bögemann M, Weckesser M

Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18

Voltin CA, Goergen H, Baues C, Fuchs M, Mettler J, Kreissl S, Oertl J, Klaeser B, Moccia A, Drzezga A, Engert A, Borchmann P, Dietlein M, Kobe C

Optimized synthesis and indium complex formation with the bifunctional chelator NODIA-Me

Weinmann C, Holland JP, Läppchen T, Scherer H, Maus S, Stemler T, Bohnenberger H, Ezziddin S, Kurz P, Bartholomä MD

Prospective comparison of 68Ga-PSMA PET/CT, 18F-sodium fluoride PET/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancer

Zacho HD, Nielsen JB, Afshar Oromieh A, Haberkorn U, deSouza N, De Paepe K, Dettmann K, Langkilde NC, Haarmark C, Fisker RV, Arp DT, Carl J, Jensen JB, Petersen LJ

Neuro-PET – ein Update

Beyer L, Rominger AO

Bildgebung bei Epilepsie: Neue Ansätze in Forschung und Praxis

Wiest R, Rominger AO

Imaging and radiotherapy for recurrent prostate cancer: An evolutionary partnership

Murray JR, Kopka K, Afshar-Oromieh A

Tracer uptake in mediastinal lymph nodes as a potential pitfall in image interpretation of PSMA Ligand PET/CT

Afshar Oromieh A, Sattler LP, Steiger K, Holland-Lenz T, Mier W, NeelsO, Weichert W, Haberkorn U

Left Temporal Hypometabolism in FDG-PET underlines Cognitive Reserve Hypothesis in Frontotemporal Dementia

Beyer L, Meyer-Wilmes J, Schönecker S, Schnabel J, Brendel E, Unterrainer M, Catak C, Pogarell O, Perneczky R, Danek A, Bürger K, Bartenstein P, Levin J, Rominger AO, Brendel M

Neuronal Injury Biomarkers for Assessment of Cognitive Reserve in Alzheimer’s Disease

Beyer L, Schnabel J, Kazmierczak P, Schönecker S, Prix C, Meyer-Wilmes J, Unterrainer M, Catak C, Pogarell O, Perneczky R, Ewers M, Bartenstein P, Danek A, Bürger K, Levin J, Rominger AO, Brendel M

Somatostatinrezeptor-PET/CT

Boy C, Poeppel T, Kotzerke J, Krause BJ, Amthauer H, Baum RP, Buchmann I, Ezziddin S, Führer D, Gabriel M, Kuwert T, Lahner H, Lauenstein T, Maecke HR, Nagarajah J, Rösch F, Scheidhauer K, Schmidt M, Walter MA, Bockisch A

Early and longitudinal microglial activation but not fibrillar amyloid accumulation predict cognitive outcome and synaptic density in PS2APP mice

Brendel M, Focke C, Deussing M, Zott B, Blune T, Shi Y, Beyer L, Kleinberger G, Lindner S, Gildehaus F, Bartenstein P, Baumann K, Haass C, Herms J, Adelsberger H, Rominger AO

Standard protocol compared to a novel protocol for 68Ga-PSMA-PET/CT in patients with recurrent prostate cancer - which one is superior?

Dijkstra L, Haupt F, Viscione M, Fech V, Krause TM, Rominger AO, Afshar Oromieh A

Expert System for Bone Scan Interpretation Improves Progression Assessment in Bone Metastatic Prostate Cancer (Dissertation)

Haupt F

Imaging Prostate Cancer With Prostate-Specific Membrane Antigen PET/CT and PET/MRI: Current and Future Applications

Hope TA, Afshar Oromieh A, Eiber M, Emmett L, Fendler WP, Lawhn-Heath C, Rowe SP

Results of a nationwide phantom based PET-Survey in Switzerland before harmonization

Klaeser B, Prenosil G, Hentschel M, Fürstner M, Krause TM, Rominger AO, Weitzel T

Feasibility study of applying ICRP biokinetic models for pharmacokinetic modelling of alpha-emitter thorium-227 used in targeted radionuclide therapy

Li WB, Zhernosekov K, Höllriegl V, Meckel M, Ziegler S, Konijnenberg MW, Shi K

EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer.

Poeppel TD, Handkiewicz-Junak D, Andreeff M, Becherer A, Bockisch A, Fricke E, Geworski L, Heinzel A, Krause BJ, Krause TM, Mitterhauser M, Sonnenschein W, Bodei L, Delgado-Bolton RC, Gabriel M

Quantitative PET: Count Number Adaptations of Organ and Site specific Acquisition Protocols are a Key Determinant of comparable PET/CT Measurements

Prenosil G, Weitzel T, Hentschel M, Krause TM, Rominger AO, Klaeser B

PSMA Theranostics: Current Status and Future Directions

Rahbar K, Afshar Oromieh A, Jadvar H, Ahmadzadehfar H

In vivo Imaging of Microglial Activation in Patients with Clinical Suspected Progressive Supranuclear Palsy: A 18FGE180 PET study

Sauerbeck J, Beyer L, Rohrer G, Sonnenfeld S, Nübling G, Höglinger G, Bartenstein P, Levin J, Rominger AO, Brendel M

Amyloid Imaging using 18F-FIBT PET: a pilot study

Shi K, Grimmer T, Förstl H, Yakushev I, Schwaiger M, Weber W, Kurz A, Yousefi BH

Multi-Task Deep Learning for the Detection of Lesions on 68Ga-PSMA PET/CT Imaging

Shi K, Xu L, Tetteh G, Gafita A, Haupt F, Afshar Oromieh A, Eiber M, Menze BH, Rominger AO

Fully Convolutional Neural Network to Assess Skeleton Tumor Burden in Prostate Cancer Using 68Ga-PSMA-11 PET/CT: Preliminary Results

Tetteh G, Gafita A, Xu L, Zhao Y, Dong C, Rominger AO, Shi K, Zimmer C, Menze BH, Eiber M

Evaluation of Multi-Center PET/CT Quality Assurance: Multi-Paradigm Software Enables Automated PET Quality Control

Weitzel T, Prenosil G, Hentschel M, Fürstner M, Krause TM, Rominger AO, Klaeser B